NI201200178A - Nueva asociación entre la 4 - { 3 -[ cis - hexahidrociclopenta [c] pirrol - 2 (1h) - il ] propoxi } benzamida y un antagonista de los receptores nmda y las composiciones farmacéuticas que la contienen - Google Patents

Nueva asociación entre la 4 - { 3 -[ cis - hexahidrociclopenta [c] pirrol - 2 (1h) - il ] propoxi } benzamida y un antagonista de los receptores nmda y las composiciones farmacéuticas que la contienen

Info

Publication number
NI201200178A
NI201200178A NI201200178A NI201200178A NI201200178A NI 201200178 A NI201200178 A NI 201200178A NI 201200178 A NI201200178 A NI 201200178A NI 201200178 A NI201200178 A NI 201200178A NI 201200178 A NI201200178 A NI 201200178A
Authority
NI
Nicaragua
Prior art keywords
propoxi
pirrol
hexahydrocyclopenta
benzamide
antagonist
Prior art date
Application number
NI201200178A
Other languages
English (en)
Inventor
Sors Aurore
Trocme-Thibierge Caryn
Merdes Annette
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47682151&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NI201200178(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Publication of NI201200178A publication Critical patent/NI201200178A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

NUEVA ASOCIACIÓN ENTRE LA 4 - { 3 -[ CIS - HEXAHIDROCICLOPENTA [C] PIRROL - 2 (1H) - IL ] PROPOXI } BENZAMIDA Y UN ANTAGONISTA DE LOS RECEPTORES NMDA Y LAS COMPOSICIONES FARMACÉUTICAS QUE LA CONTIENEN
NI201200178A 2011-12-09 2012-12-03 Nueva asociación entre la 4 - { 3 -[ cis - hexahidrociclopenta [c] pirrol - 2 (1h) - il ] propoxi } benzamida y un antagonista de los receptores nmda y las composiciones farmacéuticas que la contienen NI201200178A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161568831P 2011-12-09 2011-12-09
FR1103777A FR2983732B1 (fr) 2011-12-09 2011-12-09 Nouvelle association entre le 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy}pharmaceutiques qui la contiennent

Publications (1)

Publication Number Publication Date
NI201200178A true NI201200178A (es) 2013-05-13

Family

ID=47682151

Family Applications (1)

Application Number Title Priority Date Filing Date
NI201200178A NI201200178A (es) 2011-12-09 2012-12-03 Nueva asociación entre la 4 - { 3 -[ cis - hexahidrociclopenta [c] pirrol - 2 (1h) - il ] propoxi } benzamida y un antagonista de los receptores nmda y las composiciones farmacéuticas que la contienen

Country Status (27)

Country Link
US (2) US8921409B2 (es)
EP (1) EP2601942A1 (es)
JP (1) JP5591310B2 (es)
KR (1) KR101489670B1 (es)
CN (1) CN103157111B (es)
AP (1) AP3225A (es)
AR (1) AR089112A1 (es)
AU (1) AU2012258339A1 (es)
BR (1) BR102012031031A2 (es)
CA (1) CA2798549A1 (es)
CL (1) CL2012003437A1 (es)
CO (2) CO6660080A1 (es)
CR (1) CR20120608A (es)
EA (1) EA201201530A1 (es)
EC (1) ECSP12012329A (es)
FR (1) FR2983732B1 (es)
GT (1) GT201200329A (es)
MA (1) MA34867B1 (es)
MD (1) MD4348B1 (es)
MX (1) MX2012014184A (es)
NI (1) NI201200178A (es)
PE (1) PE20130813A1 (es)
SG (1) SG191494A1 (es)
TN (1) TN2012000563A1 (es)
TW (1) TWI457123B (es)
UY (1) UY34475A (es)
WO (1) WO2013083887A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3003466B1 (fr) * 2013-03-22 2015-08-07 Servier Lab Utilisation du 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy}benzamide pour le traitement des douleurs neuropathiques
KR101484405B1 (ko) * 2013-08-14 2015-01-19 서울대학교산학협력단 Ｎｉｎｊｕｒｉｎ１ 결핍 유래의 강박증 예방 또는 치료용 약학적 조성물
GB201509134D0 (en) * 2015-05-28 2015-07-15 Electrophoretics Ltd Biomolecules involved in Alzheimer's disease
EP3324956A4 (en) * 2015-07-22 2019-02-20 Anavex Life Sciences Corp. ENANTIOMERS OF TETRAHYDRO-N, N-DIMETHYL-2,2-DIPHENYL-3-FURANMETHANAMINE (ANAVEX2-73) AND USE THEREOF IN THE TREATMENT OF MORBUS ALZHEIMER AND OTHER FAILURES MODULATED BY THE SIGMA-1 RECEPTOR

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04011762A (es) * 2002-05-31 2005-03-31 Lundbeck & Co As H Una combinacion de antagonista de nmda e inhibidores de acetilcolinesterasa para el tratamiento de la enfermedad de alzheimer.
KR20060030469A (ko) * 2003-05-27 2006-04-10 포레스트 래보러토리즈, 인코포레이티드 우울증 및 그 밖의 기분장애의 치료를 위한 ｎｍｄａ수용체 길항제 및 선택적 세로토닌 재흡수 억제제의 배합물
EP1638560A1 (en) * 2003-06-20 2006-03-29 Eli Lilly And Company 3-aminopiperidines and 3-aminoquinuclidines as inhibitors of monoamine uptake
EP1703902B1 (en) * 2004-01-05 2010-11-03 Merz Pharma GmbH & Co. KGaA Memantine for the treatment of mild-to-moderate alzheimer's disease
FR2866647B1 (fr) * 2004-02-20 2006-10-27 Servier Lab Nouveaux derives azabicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
TW200531680A (en) * 2004-03-03 2005-10-01 Merz Pharma Gmbh & Co Kgaa Therapy using 1-aminocyclohexane derivatives for the treatment of behavioral disorders associated with alzheimer's disease
EP1740172A4 (en) * 2004-03-19 2007-10-10 Axonyx Inc ACETYLCHOLINESTERASE INHIBITORS AND N-METHYL-D-ASPARTATE ANTAGONISTS FOR THE TREATMENT OF COGNITIVE DISORDER
FR2937119B1 (fr) 2008-10-15 2010-12-17 Air Liquide Procede de production d'energie et capture de co2
FR2937251B1 (fr) * 2008-10-16 2011-03-18 Servier Lab Utilisation du 4-{3-°hexahydrocyclopenta°c!pyrrol-2(1h)-yl! propoxy}benzamide pour l'obtention de medicaments destines au traitement des troubles du sommeil
FR2953515B1 (fr) * 2009-12-09 2011-12-23 Servier Lab Nouveaux derives du type hexahydrocyclopenta[b]pyrrole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
MA34867B1 (fr) 2014-02-01
TN2012000563A1 (fr) 2014-04-01
US8921409B2 (en) 2014-12-30
KR101489670B1 (ko) 2015-02-04
CN103157111B (zh) 2015-02-11
AU2012258339A1 (en) 2013-06-27
WO2013083887A1 (fr) 2013-06-13
PE20130813A1 (es) 2013-07-28
CN103157111A (zh) 2013-06-19
AP3225A (en) 2015-04-30
ECSP12012329A (es) 2013-01-31
KR20130065602A (ko) 2013-06-19
JP5591310B2 (ja) 2014-09-17
EP2601942A1 (fr) 2013-06-12
NZ604084A (en) 2014-07-25
CL2012003437A1 (es) 2014-01-24
CA2798549A1 (fr) 2013-06-09
EA201201530A1 (ru) 2013-07-30
SG191494A1 (en) 2013-07-31
FR2983732B1 (fr) 2013-11-22
TWI457123B (zh) 2014-10-21
MD4348B1 (ro) 2015-05-31
GT201200329A (es) 2014-03-14
FR2983732A1 (fr) 2013-06-14
UY34475A (es) 2013-07-31
CO6660080A1 (es) 2013-04-30
US20150080448A1 (en) 2015-03-19
BR102012031031A2 (pt) 2013-10-29
JP2013121956A (ja) 2013-06-20
AR089112A1 (es) 2014-07-30
AP2012006607A0 (en) 2012-12-31
CO6690116A1 (es) 2013-06-17
CR20120608A (es) 2014-03-05
TW201334777A (zh) 2013-09-01
WO2013083887A8 (fr) 2013-08-08
MX2012014184A (es) 2013-06-18
US20130150421A1 (en) 2013-06-13

Similar Documents

Publication Publication Date Title
CO2017002532A2 (es) Indazoles sustituidos con bencilo como inhibidores de bub1
CR20140106A (es) Compuestos y composiciones como inhibidores de la quinasa c-kit
UY34220A (es) Indazoles, composiciones farmacéuticas y uso de los mismos
CO7020912A2 (es) Inhibidores de bromodominios
CR20140501A (es) Nuevos diazaespirocicloalcanos y azaespirocicloalcanos
CO6960547A2 (es) Dispersión sólida de un inhibidor erb2 (her2)
CO7091177A2 (es) Inhibidores de la beta-secretasa
AR094204A1 (es) Composiciones para el cuidado oral que contienen haluros de acido amino
UY33958A (es) Inhibidores de la glucosilceramida sintasa
UY33930A (es) Inhibidores novedosos de quinasas
UY33906A (es) Composiciones herbicidas que comprenden topramezona
UA109931C2 (xx) Піримідинциклогексильні модулятори глюкокортикоїдних рецепторів
CO7020907A2 (es) Inhibidores de quinurenina-3-monooxigenasa, composiciones farmacéuticas y métodos de uso de los mismos
DK3489226T3 (da) Hæmmere for natriumglucose-cotransporter 1
RS57232B1 (sr) Jedinjenja koja imaju muskarinske receptore aktivnosti antagonista i beta2 adrenergik receptore aktivnosti agonista
CO7141409A2 (es) Composiciones tópicas que comprenden fipronilo y permetrina y sus métodos de uso
UY34193A (es) Aparato para medir un objeto
UY34115A (es) Ensayo de la lisil oxidasa-like 2 y sus métodos de empleo
CR20120192A (es) Nueva asociación entre la 4{3-[cis-hexahidrociclopenta[c]pirrol-2(1h)-il]propoxi}benzamida y un inhibidor de la acetilcolinesterasa y las composiciones farmacéuticas que la contienen
BR112014003027A2 (pt) formulação herbicida melhorada
UY34158A (es) Composicion herbicida
UY34197A (es) NUEVOS ANTAGONISTAS DE CRTh2
UY34243A (es) Marcadores y metodos para evaluación del riesgo de enfermedades cardiovasculares
CO2018002440A2 (es) Compuestos útiles para inhibir ror-gamma-t
UY34166A (es) Composición farmacéutica oftalmológica tópica que contiene regorafenib